BioSpace News Archive

Approval based on GEMINI pivotal trials in which Dovato achieved non-inferior efficacy compared to a dolutegravir-based, traditional, three-drug regimen through 48 weeks, with no cases of resistance1

Alkermes plc announced that Jim Robinson, President and Chief Operating Officer, has resigned from his position and will leave the company, effective April 19, 2019, for personal reasons.

Breakthrough medical platform offers vision of personalized tumor treatments with its novel sonic beam therapy

Companies to Also Jointly Advance Select Number of Preclinical Disease Programs with Targets Expressed in the Liver and Treatments for C5 Complement-Mediated Diseases

Advanced semiconductor-based platform offers diverse libraries with complete coverage of only desired variants

Digital Boom and Millennials are Growing the Category, Wellness and Self-Care are New Key Drivers, Interest is in Eyes and Body Contouring

RNA whole-transcriptome and machine learning platform enables genomic test to distinguish benign Hürthle cells, reducing potential for unnecessary surgeries

Cohen Veterans Bioscience (CVB), a translational research organization dedicated to fast-tracking personalized diagnostics and therapeutics for brain health, today announces findings from a study which identifies a critical brain imaging biomarker that may help guide people who suffer from PTSD towards the most effective treatment.

Blue Cross and Blue Shield of Texas (BCBSTX) today announced it is partnering with Sanitas USA to open 10 advanced primary care medical centers in Dallas and Houston.

GD Entertainment And Technology (OTC: GDET) (“GDET” or the “Company”) today introduced a sneak-peek of its new Ecommerce website for selling its all new hemp derived CBD products produced by GDET’s recently launched cannabis sector subsidiary, “The Greenery.”